You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Lipitor impact on developing fetus?



Lipitor, also known as atorvastatin, is a medication used to treat high cholesterol levels. It is classified as a pregnancy category X drug, which means that it is contraindicated for use during pregnancy as it can cause harm to the developing fetus [1]. The FDA has issued a warning that atorvastatin should not be used during pregnancy as it can cause fetal harm, including fetal death or congenital anomalies [2].

According to the drug label, animal studies have shown that atorvastatin can cause fetal harm when administered to pregnant animals. There are no adequate and well-controlled studies in pregnant women, and the drug should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus [3].

In addition, the drug label advises that women of childbearing potential should use effective contraception while taking atorvastatin, and that breastfeeding should be avoided while taking the medication [3].

In summary, Lipitor should not be used during pregnancy as it can cause harm to the developing fetus. Women of childbearing potential should use effective contraception while taking the medication, and breastfeeding should be avoided. It is important to consult with a healthcare provider before taking any medication during pregnancy or while breastfeeding.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://www.fda.gov/media/150774/download
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s057lbl.pdf



Follow-up:   Is lipitor safe during pregnancy? What are the risks of taking lipitor while pregnant? Can lipitor harm a developing fetus?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.